```html

Yellowness of the Sclera After Medication

What is Yellowness of the Sclera after medication?

Yellowness of the sclera (the white part of the eye) that develops after starting a medication is a visual sign that something in the body’s metabolism or liver function has changed. The sclera becomes yellow because of an accumulation of bilirubin, a yellow pigment produced when red blood cells break down. Normally the liver processes bilirubin and eliminates it in the stool, but certain drugs can interfere with this pathway, leading to a temporary or, less often, permanent “jaundice” of the eyes.

While occasional, mild discoloration may be harmless, it can also be the first clue of a drug‑induced liver injury, hemolysis (breakdown of red cells), or a systemic reaction that requires urgent medical attention. Understanding why this happens and what to look for helps patients act quickly and avoid serious complications.

Common Causes

The following medications and drug‑related conditions are most frequently linked to scleral yellowing:

• Acetaminophen (Tylenol) overdose or chronic high‑dose use – toxic to liver cells.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – especially ibuprofen or naproxen in high doses for prolonged periods.
• Antibiotics – especially amoxicillin‑clavulanate, ceftriaxone, and some sulfonamides.
• Antituberculosis drugs – isoniazid, rifampin, and pyrazinamide can cause cholestatic hepatitis.
• Antiepileptic medications – valproic acid, carbamazepine, and phenytoin.
• Statins – high‑intensity cholesterol‑lowering drugs occasionally lead to liver enzyme elevation.
• Antiretroviral therapy (ART) – especially protease inhibitors and efavirenz.
• Herbal and dietary supplements – kava, green tea extracts, and high‑dose vitamin A.
• Chemotherapy agents – methotrexate, cyclophosphamide, and 5‑fluorouracil can cause hepatic toxicity.
• Immune‑modulating drugs – checkpoint inhibitors (e.g., nivolumab) and biologics used for autoimmune disease.

Associated Symptoms

Yellowing of the sclera rarely occurs in isolation. Look for other signs that may point toward liver dysfunction, hemolysis, or a systemic reaction:

• Yellowing of the skin (especially on the palms and the yellow‑brown color of urine) – classic jaundice.
• Dark, “tea‑colored” urine or pale, clay‑colored stools.
• Upper‑right abdominal pain or a feeling of fullness under the ribs.
• Fatigue, weakness, or unexplained loss of appetite.
• Nausea, vomiting, or a poor tolerance for fatty foods.
• Itching (pruritus) without a rash, common in cholestatic jaundice.
• Fever, chills, or night sweats – may suggest infection or drug‑induced fever.
• Joint or muscle aches, especially with statins or antiepileptics.
• Red or brown discoloration of the eyes (scleral icterus) that progresses to a yellow hue.

When to See a Doctor

Because scleral yellowing can be an early sign of a potentially serious condition, contact a health professional promptly if you notice any of the following:

• Yellow discoloration that persists longer than 24–48 hours after starting a new medication.
• Accompanying jaundice of the skin, dark urine, or pale stools.
• Severe abdominal pain, especially in the right upper quadrant.
• Sudden onset of confusion, drowsiness, or difficulty concentrating (possible hepatic encephalopathy).
• Unexplained fever, chills, or a rapid heart rate.
• Swelling of the abdomen or legs (ascites or edema).
• Any bleeding tendency such as easy bruising, nosebleeds, or bleeding gums.

Even if you feel well, it is worth calling your prescriber to discuss whether the medication should be paused or switched.

Diagnosis

Evaluation typically follows a step‑wise approach:

1. Detailed History

• Medication list – dose, start date, and any recent changes.
• Alcohol intake, herbal supplement use, and over‑the‑counter drugs.
• Travel history, recent infections, or exposure to toxins.

2. Physical Examination

• Inspection of the sclera and skin for yellowing.
• Abdominal palpation for liver enlargement or tenderness.
• Assessment of signs of chronic liver disease (spider angiomas, palmar erythema).

3. Laboratory Tests

• Liver function panel – ALT, AST, ALP, GGT, total and direct bilirubin.
• Complete blood count (CBC) – to look for hemolysis or infection.
• Coagulation profile (PT/INR) – liver synthetic function.
• Serum haptoglobin and LDH – markers of red‑cell breakdown.
• Viral hepatitis panel when indicated.

4. Imaging (if needed)

• Abdominal ultrasound – evaluates liver size, bile ducts, and gallbladder.
• CT or MRI – for more detailed anatomy if obstruction is suspected.

5. Specialized Tests

• Drug‑induced liver injury (DILI) scoring systems (e.g., RUCAM).
• Liver biopsy – rarely required but may be considered for unclear cases.

Treatment Options

Treatment focuses on eliminating the offending agent, supporting liver function, and managing symptoms.

1. Discontinue or Adjust the Medication

• Stop the suspected drug under physician guidance.
• Switch to an alternative with a safer hepatic profile.
• Gradual taper may be required for certain drugs (e.g., anticonvulsants).

2. Supportive Care

• Hydration – adequate oral fluids help the liver flush toxins.
• Nutrition – a balanced diet rich in protein (unless contraindicated) and low in saturated fats.
• Vitamin K supplementation if clotting factors are low.
• Antipruritic agents (e.g., cholestyramine or antihistamines) for itching.

3. Pharmacologic Interventions

• N‑acetylcysteine (NAC) – antidote for acetaminophen toxicity; can also benefit non‑acetaminophen DILI.
• Corticosteroids – occasionally used for severe immune‑mediated drug reactions.
• Ursodeoxycholic acid – may improve cholestatic jaundice caused by certain drugs.

4. Monitoring

• Repeat liver function tests every 48–72 hours until values trend down.
• Long‑term follow‑up if bilirubin remains elevated or if chronic liver disease is uncovered.

5. When Liver Damage Is Advanced

• Referral to a hepatologist.
• Consideration of liver transplantation for fulminant hepatic failure (rare, but life‑saving).

Prevention Tips

• Know your medications – keep an up‑to‑date list and read the patient information leaflet for liver‑related warnings.
• Use the lowest effective dose – especially for acetaminophen, NSAIDs, and statins.
• Avoid alcohol while taking potentially hepatotoxic drugs.
• Schedule regular lab checks if you are on long‑term therapy known to affect the liver (e.g., antiretrovirals, methotrexate).
• Stay hydrated and maintain a healthy weight to reduce baseline liver stress.
• Discuss herbal supplements with your clinician before adding them to your regimen.
• Report any new symptoms (e.g., dark urine, abdominal pain) to your healthcare provider promptly.

Emergency Warning Signs

---

**Sources:** Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, peer‑reviewed journals on drug‑induced liver injury (e.g., *Hepatology*, *Journal of Clinical Gastroenterology*).

```